GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ilex Medical Ltd (XTAE:ILX) » Definitions » EV-to-EBITDA

Ilex Medical (XTAE:ILX) EV-to-EBITDA : 4.31 (As of Jun. 24, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Ilex Medical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ilex Medical's enterprise value is ₪510.4 Mil. Ilex Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₪118.5 Mil. Therefore, Ilex Medical's EV-to-EBITDA for today is 4.31.

The historical rank and industry rank for Ilex Medical's EV-to-EBITDA or its related term are showing as below:

XTAE:ILX' s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.06   Med: 6.42   Max: 24.66
Current: 4.31

During the past 11 years, the highest EV-to-EBITDA of Ilex Medical was 24.66. The lowest was 1.06. And the median was 6.42.

XTAE:ILX's EV-to-EBITDA is ranked better than
88.54% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 15.225 vs XTAE:ILX: 4.31

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-24), Ilex Medical's stock price is ₪62.61. Ilex Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₪5.000. Therefore, Ilex Medical's PE Ratio for today is 12.52.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Ilex Medical EV-to-EBITDA Historical Data

The historical data trend for Ilex Medical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ilex Medical EV-to-EBITDA Chart

Ilex Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.53 6.53 5.23 4.82 4.13

Ilex Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.43 3.87 4.76 4.13 4.60

Competitive Comparison of Ilex Medical's EV-to-EBITDA

For the Medical Devices subindustry, Ilex Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ilex Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ilex Medical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ilex Medical's EV-to-EBITDA falls into.



Ilex Medical EV-to-EBITDA Calculation

Ilex Medical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=510.405/118.526
=4.31

Ilex Medical's current Enterprise Value is ₪510.4 Mil.
Ilex Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪118.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ilex Medical  (XTAE:ILX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Ilex Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=62.61/5.000
=12.52

Ilex Medical's share price for today is ₪62.61.
Ilex Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪5.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Ilex Medical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ilex Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ilex Medical (XTAE:ILX) Business Description

Traded in Other Exchanges
N/A
Address
Kodak Building, 7 Hatnufa Street, PO Box 3156, Kiriat Arie Industrial Park, Petah Tikva, ISR, 4951025
Ilex Medical Ltd is an Israel based company engages in the marketing and distribution of diagnostic products and other medical laboratory information systems. It offers in-vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services to the healthcare sector in Israel.

Ilex Medical (XTAE:ILX) Headlines

No Headlines